Search
for
Sort by
Research 30 of 585
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Ruxolitinib 1.5% Topical Cream for the Treatment of Pediatric Alopecia Areata
- The use of topical ruxolitinib 1.5% cream in frontal fibrosing alopecia: A case report
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Alopecia Areata and Alopecia Areata Incognita
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Systemic Absorption and Pharmacokinetics of Five Novel Topical Dermatologic Agents: A Review
- 448 Combined therapeutic approach: Inhibition of MMP-9 and JAK Signaling Synergistically Prevents Depigmentation in Experimental Vitiligo
- Surgical Approaches for Repigmenting Vitiligo 2.0
- Anais do II Congresso Nacional Acadêmico de Dermatologia
- Ruxolitinib: A novel molecule in the management of dermatological disorders
- Off‐Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives
- A Case of Topical Ruxolitinib Treatment Failure in Alopecia Areata
- Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata
- Fast clinical response with topical ruxolitinib in the management of non-segmental vitiligo detected by VISIA<sup>®</sup> analysis system
- A pilot study of 2% tofacitinib cream with narrowband ultraviolet B for the treatment of facial vitiligo
- Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature
- Ruxolitinib found to cause eyelash growth: a case report
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
- Topical Ruxolitinib in Combination with Oral Minoxidil Results in Hair Regrowth in a Patient with Central Centrifugal Cicatricial Alopecia and Concomitant Traction Alopecia
- New drugs under investigation for the treatment of alopecias
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Delayed granulomatous eruption of the nose associated with ruxolitinib
- Amlodipine topical cream: an effective hair growth promoter for an alopecia mouse model via VEGF-mediated angiogenesis and vasodilation
- A Concise Review on Novel Drugs Applied in Treatment of Alopecia
- Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1
- Small Molecule Inhibitors and Inflammatory Skin Diseases
- Montagna Symposium 2017—Precision Dermatology: Next Generation Prevention, Diagnosis, and Treatment
- Treating Alopecia Areata: Current Practices Versus New Directions